Meeting
2019 Gastrointestinal Cancers Symposium
Impact of cardiac comorbidity on use and outcomes of adjuvant chemotherapy (ADJ) for colorectal cancer (CRC): A real-world population-based study.
Authors
Shiru Lucy Liu
BC Cancer, Vancouver, BC, Canada
Shiru Lucy Liu , Sharlene Gill , Winson Y. Cheung
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 491)
DOI
10.1200/JCO.2019.37.4_suppl.491
Abstract #
491
Poster Bd #
C12
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world impact on overall survival of oxaliplatin-based adjuvant chemotherapy in older patients with colorectal cancer in Mexico.
First Author: Marytere Herrera
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world adoption of 3 months of adjuvant oxaliplatin chemotherapy in patients with stage III colorectal cancer (CRC).
First Author: Tharani Krishnan
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world evidence of FOLFIRI combined with anti-angiogenesis inhibitors or anti-EGFR antibodies for patients with early recurrence colorectal cancer after adjuvant FOLFOX/CAPOX therapy in Japan: A retrospective observational study using administrative database.
First Author: Yu Sunakawa
Poster
2023 ASCO Annual Meeting
Chemotherapeutic sensitivity in colorectal cancer expressing low RNA of wild type homologous recombination genes.
First Author: Daniel Walden